세계의 누트로픽(Nootropics) 시장 규모, 점유율, 동향 분석 보고서 : 유통 채널별, 형태별, 지역별 전망 및 예측(2025-2032년)

Global Nootropics Market Size, Share & Trends Analysis Report By Distribution Channel (Offline and Online), By Form (Capsules & Tablets, Powder, Drinks, and Other Form), By Regional Outlook and Forecast, 2025 - 2032

US $ 3,600 ￦ 5,344,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,413,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,979,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

누트로픽(뇌기능 개선제) 시장 규모는 예측 기간 중에 14.3%의 연평균 복합 성장률(CAGR)로 성장하여 2032년까지 133억 1,000만 달러에 이를 것으로 예상되고 있습니다.

최근 몇년사이 예방적 건강관리로 큰 변화가 일어나고 있으며, 사람들은 병에 걸린 후의 치료뿐만 아니라 장기적인 건강을 중요하게 여기고 있습니다. 이러한 변화는 스스로 건강을 관리하고자 하는 욕구가 높아지면서 건강보조식품과 건강식품을 일상 생활에 도입하는 사람들이 늘어나고 있습니다. Nutropic은 이러한 흐름에 완벽하게 부합하며, 뇌 건강 유지, 정신 능력 향상 및 전반적인 건강 증진에 대한 적극적인 접근 방식을 제공합니다. 따라서 예방적 건강관리의 확산은 누 트로픽에 대한 수요를 자극하고 전 세계 소비자의 건강 습관에 더욱 깊숙이 뿌리내리고 있다고 할 수 있습니다.

그러나 뉴트로픽의 보급을 가로막는 큰 장벽 중 하나는 고가의 처방과 처방전이 필요한 제형에 따른 높은 비용입니다. 뉴트로픽은 인지기능 개선 효과를 제공하지만, 일부 제품은 고가의 가격대를 형성하고 있어 많은 사람들이 접근하기 어려운 것이 사실입니다. 고가의 성분이나 독자적인 블렌드를 사용하는 경우가 많은 프리미엄 영양제는 많은 사람들, 특히 저소득층이나 개발도상국의 사람들에게는 가격이 너무 비싸서 접근하기 어려울 수 있습니다. 따라서 프리미엄 및 처방전이 필요한 뉴트로픽의 고비용은 시장 성장을 저해하는 요인으로 작용하고 있습니다.

유통채널별 전망

유통 채널에 따라 시장은 오프라인과 온라인으로 분류됩니다. 온라인 부문은 2024년 시장 수익의 28%를 차지했습니다. 이 부문의 성장은 인터넷 보급률 증가, 스마트폰 사용 증가, 그리고 택배의 편의성에 의해 주도되었습니다. 소비자들은 경쟁력 있는 가격, 제품 리뷰, 세계 브랜드에 대한 접근성에 매료되어 다양한 누트로픽 제품을 찾기 위해 이커머스 플랫폼을 이용하고 있습니다. 디지털 마케팅 전략과 인플루언서 중심의 프로모션의 성장도 이 부문에서 인지도를 높이고 온라인 판매를 늘리는 데 중요한 역할을 했습니다.

형태별 전망

형태에 따라 시장은 캡슐/정제, 분말, 음료, 기타로 분류됩니다. 분말 부문은 2024년 시장에서 25%의 매출 점유율을 차지할 것으로 예측됩니다. 이 형태는 피트니스 애호가, 학생, 그리고 맞춤형 복용량과 빠른 흡수를 선호하는 건강 지향적 인 사람들 사이에서 인기를 얻었습니다. 분말은 종종 스무디와 건강 음료에 사용되며, 사용자는 일상 생활에 영양제를 쉽게 통합 할 수 있습니다. 개인화된 영양에 대한 수요 증가와 맛과 향이 있는 분말과 없는 분말 옵션의 가용성이 이 부문의 성장에 크게 기여했습니다.

지역별 전망

지역별로는 북미, 유럽, 아시아태평양, LAMEA(라 메리아, 중동 및 아프리카)로 시장을 분석했습니다. 아시아태평양은 2024년 시장 매출의 26%를 차지할 것으로 예측됩니다. 이러한 성장은 중국, 인도, 일본, 한국 등의 국가에서 건강에 대한 인식이 높아지고, 도시화가 진행되면서 정신 건강에 대한 관심이 높아진 것이 주요 요인으로 작용하고 있습니다. 이 지역에서는 특히 젊은 성인과 학생들 사이에서 뇌건강 보충제에 대한 수요가 급증하고 있습니다.

목차

제1장 시장 범위와 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 개관

• 주요 하이라이트

제3장 시장 개요

• 서론
  • 개요
    • 시장 구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장이 해결해야 할 과제
• Porter의 Five Forces 분석

제4장 세계 시장 : 유통 채널별

• 세계의 오프라인 시장 : 지역별
• 세계의 온라인 시장 : 지역별

제5장 세계 시장 : 형태별

• 세계의 캡슐 및 정제 시장 : 지역별
• 세계의 분말 시장 : 지역별
• 세계의 음료 시장 : 지역별
• 세계의 기타 폼 시장 : 지역별

제6장 세계 시장 : 지역별

• 북미
  • 북미 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 싱가포르
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카/중동 및 아프리카
  • 라틴아메리카/중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트(UAE)
    • 사우디아라비아
    • 남아프리카공화국
    • 나이지리아
    • 기타 라틴아메리카/중동 및 아프리카

제7장 기업 개요

• Onnit Labs, Inc
• Reckitt Benckiser Group PLC
• Natural Stacks
• Mind Lab Pro(Opti-Nutra, ltd)
• PowderCitycom,Ltd
• NOW Foods, Inc
• Purelife Bioscience Co, Ltd.
• Peak Nootropics
• AlternaScript
• Teva Pharmaceutical Industries Ltd

제8장 누트로픽 시장을 위한 성공 필수 조건

LSH

영문 목차

영문목차

The Global Nootropics Market size is expected to reach $13.31 billion by 2032, rising at a market growth of 14.3% CAGR during the forecast period.

The North America segment recorded 40% revenue share in the market in 2024. The strong market presence in this region can be attributed to the growing consumer awareness regarding cognitive enhancers, the widespread availability of nootropic products, and the well-established health and wellness industry. Additionally, the increasing adoption of dietary supplements among working professionals, students, and older adults further propelled the demand for nootropics.

As awareness around cognitive health and mental performance grows, individuals increasingly seek ways to enhance their mental abilities, memory, focus, and overall brain health. This awareness is being fuelled by a combination of factors, including the rise of social media, increased scientific research, and the increasing importance placed on mental wellness. The modern lifestyle, filled with multitasking, high stress, and a constant demand for peak performance, has led many to recognize the significance of maintaining cognitive sharpness. Thus, increasing awareness about cognitive health and mental performance enhancement drives the market's growth.

Additionally, In recent years, there has been a significant shift toward preventive healthcare, as individuals prioritize long-term wellness rather than solely focusing on treating illnesses once they arise. This shift is driven by a growing desire to take control of one's health, and people are increasingly incorporating supplements and wellness products into their daily routines. Nootropics fit perfectly into this movement, offering a proactive approach to maintaining brain health, boosting mental performance, and enhancing overall well-being. Therefore, as such, the growing adoption of preventive healthcare practices is undoubtedly fuelling the demand for nootropics, further embedding them into the wellness routines of consumers worldwide.

However, One of the significant barriers hindering the widespread adoption of nootropics is the high cost associated with premium or prescription-based formulations. While nootropics offer cognitive enhancement benefits, the high price tag of certain products limits their accessibility to a larger portion of the population. Premium nootropic formulations, which often include a combination of expensive ingredients or proprietary blends, can be cost-prohibitive for many individuals, particularly those in lower income brackets or developing regions. Thus, the high cost of premium or prescription-based nootropic formulations restricting accessibility is impeding the growth of the market.

Distribution Channel Outlook

On the basis of distribution channel, the market is classified into offline and online. The online segment recorded 28% revenue share in the market in 2024. This segment's growth was fuelled by increasing internet penetration, rising smartphone usage, and the convenience of home delivery. Consumers increasingly turned to e-commerce platforms for a wide variety of nootropic products, attracted by competitive pricing, product reviews, and access to global brands. The growth of digital marketing strategies and influencer-driven promotions also played a vital role in enhancing visibility and boosting online sales in this segment.

Form Outlook

Based on form, the market is characterized into capsules/tablets, powder, drinks, and others. The powder segment procured 25% revenue share in the market in 2024. This form gained traction among fitness enthusiasts, students, and health-conscious individuals who preferred customizable dosages and quick absorption. Powders are often used in smoothies or health drinks, allowing users to integrate nootropics into their daily routines easily. The increasing demand for personalized nutrition and the availability of flavoured and unflavoured powder options contributed significantly to the growth of this segment.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment witnessed 26% revenue share in the market in 2024. This growth was driven by rising health consciousness, increasing urbanization, and a growing focus on mental well-being across countries like China, India, Japan, and South Korea. The region has witnessed a surge in demand for brain health supplements, especially among young adults and students.

List of Key Companies Profiled

• Onnit Labs, Inc.
• Reckitt Benckiser Group PLC
• Natural Stacks
• Mind Lab Pro (Opti-Nutra, ltd.)
• PowderCity.com,Ltd
• NOW Foods, Inc.
• Purelife Bioscience Co., Ltd.
• Peak Nootropics
• AlternaScript
• Teva Pharmaceutical Industries Ltd.

Global Nootropics Market Report Segmentation

By Distribution Channel

• Offline
• Online

By Form

• Capsules & Tablets
• Powder
• Drinks
• Other Form

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Nootropics Market, by Distribution Channel
  • 1.4.2 Global Nootropics Market, by Form
  • 1.4.3 Global Nootropics Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Nootropics Market by Distribution Channel

• 4.1 Global Offline Market by Region
• 4.2 Global Online Market by Region

Chapter 5. Global Nootropics Market by Form

• 5.1 Global Capsules & Tablets Market by Region
• 5.2 Global Powder Market by Region
• 5.3 Global Drinks Market by Region
• 5.4 Global Other Form Market by Region

Chapter 6. Global Nootropics Market by Region

• 6.1 North America Nootropics Market
  • 6.1.1 North America Nootropics Market by Distribution Channel
    • 6.1.1.1 North America Offline Market by Region
    • 6.1.1.2 North America Online Market by Region
  • 6.1.2 North America Nootropics Market by Form
    • 6.1.2.1 North America Capsules & Tablets Market by Country
    • 6.1.2.2 North America Powder Market by Country
    • 6.1.2.3 North America Drinks Market by Country
    • 6.1.2.4 North America Other Form Market by Country
  • 6.1.3 North America Nootropics Market by Country
    • 6.1.3.1 US Nootropics Market
      • 6.1.3.1.1 US Nootropics Market by Distribution Channel
      • 6.1.3.1.2 US Nootropics Market by Form
    • 6.1.3.2 Canada Nootropics Market
      • 6.1.3.2.1 Canada Nootropics Market by Distribution Channel
      • 6.1.3.2.2 Canada Nootropics Market by Form
    • 6.1.3.3 Mexico Nootropics Market
      • 6.1.3.3.1 Mexico Nootropics Market by Distribution Channel
      • 6.1.3.3.2 Mexico Nootropics Market by Form
    • 6.1.3.4 Rest of North America Nootropics Market
      • 6.1.3.4.1 Rest of North America Nootropics Market by Distribution Channel
      • 6.1.3.4.2 Rest of North America Nootropics Market by Form
• 6.2 Europe Nootropics Market
  • 6.2.1 Europe Nootropics Market by Distribution Channel
    • 6.2.1.1 Europe Offline Market by Country
    • 6.2.1.2 Europe Online Market by Country
  • 6.2.2 Europe Nootropics Market by Form
    • 6.2.2.1 Europe Capsules & Tablets Market by Country
    • 6.2.2.2 Europe Powder Market by Country
    • 6.2.2.3 Europe Drinks Market by Country
    • 6.2.2.4 Europe Other Form Market by Country
  • 6.2.3 Europe Nootropics Market by Country
    • 6.2.3.1 Germany Nootropics Market
      • 6.2.3.1.1 Germany Nootropics Market by Distribution Channel
      • 6.2.3.1.2 Germany Nootropics Market by Form
    • 6.2.3.2 UK Nootropics Market
      • 6.2.3.2.1 UK Nootropics Market by Distribution Channel
      • 6.2.3.2.2 UK Nootropics Market by Form
    • 6.2.3.3 France Nootropics Market
      • 6.2.3.3.1 France Nootropics Market by Distribution Channel
      • 6.2.3.3.2 France Nootropics Market by Form
    • 6.2.3.4 Russia Nootropics Market
      • 6.2.3.4.1 Russia Nootropics Market by Distribution Channel
      • 6.2.3.4.2 Russia Nootropics Market by Form
    • 6.2.3.5 Spain Nootropics Market
      • 6.2.3.5.1 Spain Nootropics Market by Distribution Channel
      • 6.2.3.5.2 Spain Nootropics Market by Form
    • 6.2.3.6 Italy Nootropics Market
      • 6.2.3.6.1 Italy Nootropics Market by Distribution Channel
      • 6.2.3.6.2 Italy Nootropics Market by Form
    • 6.2.3.7 Rest of Europe Nootropics Market
      • 6.2.3.7.1 Rest of Europe Nootropics Market by Distribution Channel
      • 6.2.3.7.2 Rest of Europe Nootropics Market by Form
• 6.3 Asia Pacific Nootropics Market
  • 6.3.1 Asia Pacific Nootropics Market by Distribution Channel
    • 6.3.1.1 Asia Pacific Offline Market by Country
    • 6.3.1.2 Asia Pacific Online Market by Country
  • 6.3.2 Asia Pacific Nootropics Market by Form
    • 6.3.2.1 Asia Pacific Capsules & Tablets Market by Country
    • 6.3.2.2 Asia Pacific Powder Market by Country
    • 6.3.2.3 Asia Pacific Drinks Market by Country
    • 6.3.2.4 Asia Pacific Other Form Market by Country
  • 6.3.3 Asia Pacific Nootropics Market by Country
    • 6.3.3.1 China Nootropics Market
      • 6.3.3.1.1 China Nootropics Market by Distribution Channel
      • 6.3.3.1.2 China Nootropics Market by Form
    • 6.3.3.2 Japan Nootropics Market
      • 6.3.3.2.1 Japan Nootropics Market by Distribution Channel
      • 6.3.3.2.2 Japan Nootropics Market by Form
    • 6.3.3.3 India Nootropics Market
      • 6.3.3.3.1 India Nootropics Market by Distribution Channel
      • 6.3.3.3.2 India Nootropics Market by Form
    • 6.3.3.4 South Korea Nootropics Market
      • 6.3.3.4.1 South Korea Nootropics Market by Distribution Channel
      • 6.3.3.4.2 South Korea Nootropics Market by Form
    • 6.3.3.5 Singapore Nootropics Market
      • 6.3.3.5.1 Singapore Nootropics Market by Distribution Channel
      • 6.3.3.5.2 Singapore Nootropics Market by Form
    • 6.3.3.6 Malaysia Nootropics Market
      • 6.3.3.6.1 Malaysia Nootropics Market by Distribution Channel
      • 6.3.3.6.2 Malaysia Nootropics Market by Form
    • 6.3.3.7 Rest of Asia Pacific Nootropics Market
      • 6.3.3.7.1 Rest of Asia Pacific Nootropics Market by Distribution Channel
      • 6.3.3.7.2 Rest of Asia Pacific Nootropics Market by Form
• 6.4 LAMEA Nootropics Market
  • 6.4.1 LAMEA Nootropics Market by Distribution Channel
    • 6.4.1.1 LAMEA Offline Market by Country
    • 6.4.1.2 LAMEA Online Market by Country
  • 6.4.2 LAMEA Nootropics Market by Form
    • 6.4.2.1 LAMEA Capsules & Tablets Market by Country
    • 6.4.2.2 LAMEA Powder Market by Country
    • 6.4.2.3 LAMEA Drinks Market by Country
    • 6.4.2.4 LAMEA Other Form Market by Country
  • 6.4.3 LAMEA Nootropics Market by Country
    • 6.4.3.1 Brazil Nootropics Market
      • 6.4.3.1.1 Brazil Nootropics Market by Distribution Channel
      • 6.4.3.1.2 Brazil Nootropics Market by Form
    • 6.4.3.2 Argentina Nootropics Market
      • 6.4.3.2.1 Argentina Nootropics Market by Distribution Channel
      • 6.4.3.2.2 Argentina Nootropics Market by Form
    • 6.4.3.3 UAE Nootropics Market
      • 6.4.3.3.1 UAE Nootropics Market by Distribution Channel
      • 6.4.3.3.2 UAE Nootropics Market by Form
    • 6.4.3.4 Saudi Arabia Nootropics Market
      • 6.4.3.4.1 Saudi Arabia Nootropics Market by Distribution Channel
      • 6.4.3.4.2 Saudi Arabia Nootropics Market by Form
    • 6.4.3.5 South Africa Nootropics Market
      • 6.4.3.5.1 South Africa Nootropics Market by Distribution Channel
      • 6.4.3.5.2 South Africa Nootropics Market by Form
    • 6.4.3.6 Nigeria Nootropics Market
      • 6.4.3.6.1 Nigeria Nootropics Market by Distribution Channel
      • 6.4.3.6.2 Nigeria Nootropics Market by Form
    • 6.4.3.7 Rest of LAMEA Nootropics Market
      • 6.4.3.7.1 Rest of LAMEA Nootropics Market by Distribution Channel
      • 6.4.3.7.2 Rest of LAMEA Nootropics Market by Form

Chapter 7. Company Profiles

• 7.1 Onnit Labs, Inc.
  • 7.1.1 Company Overview
• 7.2 Reckitt Benckiser Group PLC
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
  • 7.2.4 Research & Development Expenses
  • 7.2.5 SWOT Analysis
• 7.3 Natural Stacks
  • 7.3.1 Company Overview
• 7.4 Mind Lab Pro (Opti-Nutra, ltd.)
  • 7.4.1 Company Overview
• 7.5 PowderCity.com,Ltd
  • 7.5.1 Company Overview
• 7.6 NOW Foods, Inc.
  • 7.6.1 Company Overview
  • 7.6.2 SWOT Analysis
• 7.7 Purelife Bioscience Co., Ltd.
  • 7.7.1 Company Overview
• 7.8 Peak Nootropics
  • 7.8.1 Company Overview
• 7.9 AlternaScript
  • 7.9.1 Company Overview
• 7.10. Teva Pharmaceutical Industries Ltd.
  • 7.10.1 Company Overview
  • 7.10.2 Financial Analysis
  • 7.10.3 Segmental Analysis
  • 7.10.4 Research & Development Expenses
  • 7.10.5 SWOT Analysis

Chapter 8. Winning Imperatives of Nootropics Market

관련자료